D-Index & Metrics Best Publications
Biology and Biochemistry
Switzerland
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 71 Citations 15,614 212 World Ranking 4230 National Ranking 87

Research.com Recognitions

Awards & Achievements

2023 - Research.com Biology and Biochemistry in Switzerland Leader Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Enzyme
  • DNA

Her scientific interests lie mostly in Neuroscience, Neurotrophic factors, Huntington's disease, Huntingtin and Striatum. Her research in Neurotrophic factors is mostly focused on Glial cell line-derived neurotrophic factor. Her studies deal with areas such as Glutamate receptor, Biochemistry, Ciliary neurotrophic factor and Genetic enhancement as well as Huntington's disease.

Her Huntingtin research incorporates elements of Molecular biology, Cancer research and Neurodegeneration. Her Neurodegeneration study integrates concerns from other disciplines, such as Genetics, Gene silencing and RNA interference. Her Striatum research is multidisciplinary, incorporating perspectives in Pharmacology and Pathology.

Her most cited work include:

  • Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. (1142 citations)
  • α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease (446 citations)
  • Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. (410 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of investigation include Huntingtin, Cell biology, Neuroscience, Huntington's disease and Molecular biology. Her studies in Huntingtin integrate themes in fields like Striatum and Neurodegeneration. Her Cell biology research includes themes of Programmed cell death, Astrocyte and Biochemistry.

The Neuroscience study combines topics in areas such as Glial cell line-derived neurotrophic factor, Neurotrophic factors and Viral vector. Her study in Huntington's disease is interdisciplinary in nature, drawing from both Neurotoxicity, Endocrinology and Neuroprotection. Her Molecular biology research includes elements of Cell culture, Gene expression, Transgene, NeuN and RNA interference.

She most often published in these fields:

  • Huntingtin (44.72%)
  • Cell biology (35.77%)
  • Neuroscience (34.96%)

What were the highlights of her more recent work (between 2014-2021)?

  • Huntingtin (44.72%)
  • Neuroscience (34.96%)
  • Cell biology (35.77%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Huntingtin, Neuroscience, Cell biology, Huntington's disease and Viral vector. Her Huntingtin research is multidisciplinary, relying on both Gene silencing and Striatum. Her study in the field of Astrocyte, Dopamine and Hippocampal formation also crosses realms of Prefrontal cortex.

The various areas that Nicole Déglon examines in her Cell biology study include Small hairpin RNA, Downregulation and upregulation and Gene isoform. Her research investigates the connection between Huntington's disease and topics such as Endocrinology that intersect with issues in Neuron. Her Viral vector study combines topics in areas such as Cell culture, Cell type and Induced pluripotent stem cell.

Between 2014 and 2021, her most popular works were:

  • The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases. (126 citations)
  • The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases. (126 citations)
  • The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes (54 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

Nicole Déglon mostly deals with Cell biology, Huntingtin, Neuroscience, Gene and Huntington's disease. Her research integrates issues of Small hairpin RNA, Gene silencing and microRNA in her study of Cell biology. Her work deals with themes such as Endocrinology and Energy homeostasis, which intersect with Huntingtin.

Nicole Déglon has included themes like Gene expression and Janus kinase in her Neuroscience study. Her Huntington's disease research is multidisciplinary, incorporating perspectives in AMP-activated protein kinase, AMPK, Neuron, Activator and Programmed cell death. Her Mutant study combines topics in areas such as Non-coding RNA, Cancer research, Neurodegeneration, RNA interference and Genetic enhancement.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

Jeffrey H. Kordower;Marina E. Emborg;Jocelyne Bloch;Shuang Y. Ma.
Science (2000)

1482 Citations

α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease

C. Lo Bianco;J. L. Ridet;B. L. Schneider;N. Deglon.
Proceedings of the National Academy of Sciences of the United States of America (2002)

591 Citations

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.

Patrick Aebischer;Myriam Schluep;Nicole Déglon;Jean-Marc Joseph.
Nature Medicine (1996)

540 Citations

Lentiviral-Mediated RNA Interference

Toufik Abbas-Terki;William Blanco-Bose;Nicole Déglon;William Pralong.
Human Gene Therapy (2002)

451 Citations

Isolation of multipotent neural precursors residing in the cortex of the adult human brain.

Yvan Arsenijevic;Jean-Guy Villemure;Jean-François Brunet;Jocelyne J. Bloch.
Experimental Neurology (2001)

412 Citations

In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's Disease subjects

Mathilde Faideau;Jinho Kim;Kerry Cormier;Richard Gilmore.
Human Molecular Genetics (2010)

349 Citations

Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's Disease

N. Déglon;J. L. Tseng;J.C. Bensadoun;A. D. Zurn.
Human Gene Therapy (2000)

329 Citations

Mitochondria in Huntington's disease

Maria Damiano;Laurie Galvan;Laurie Galvan;Nicole Déglon;Nicole Déglon;Emmanuel Brouillet;Emmanuel Brouillet.
Biochimica et Biophysica Acta (2010)

296 Citations

Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length

Luis Pereira de Almeida;Christopher A. Ross;Diana Zala;Diana Zala;Patrick Aebischer;Patrick Aebischer.
The Journal of Neuroscience (2002)

285 Citations

Connexin 30 sets synaptic strength by controlling astroglial synapse invasion

Ulrike Pannasch;Dominik Freche;Glenn Dallérac;Grégory Ghézali.
Nature Neuroscience (2014)

276 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nicole Déglon

Jeffrey H. Kordower

Jeffrey H. Kordower

Arizona State University

Publications: 77

Deniz Kirik

Deniz Kirik

Lund University

Publications: 65

Patrick Aebischer

Patrick Aebischer

École Polytechnique Fédérale de Lausanne

Publications: 64

Detlev Boison

Detlev Boison

Rutgers, The State University of New Jersey

Publications: 46

Frédéric Saudou

Frédéric Saudou

Grenoble Alpes University

Publications: 38

Clive N. Svendsen

Clive N. Svendsen

Cedars-Sinai Medical Center

Publications: 37

Beverly L. Davidson

Beverly L. Davidson

Children's Hospital of Philadelphia

Publications: 37

Sandrine Humbert

Sandrine Humbert

Grenoble Alpes University

Publications: 37

Bernard L. Schneider

Bernard L. Schneider

École Polytechnique Fédérale de Lausanne

Publications: 37

Michael R. Hayden

Michael R. Hayden

University of British Columbia

Publications: 36

Luc Buée

Luc Buée

University of Lille

Publications: 35

Mark H. Tuszynski

Mark H. Tuszynski

University of California, San Diego

Publications: 34

Philippe Hantraye

Philippe Hantraye

Atomic Energy and Alternative Energies Commission

Publications: 34

David Blum

David Blum

University of Lille

Publications: 33

José Luis Pedraz

José Luis Pedraz

University of the Basque Country

Publications: 31

Roger A. Barker

Roger A. Barker

University of Cambridge

Publications: 31

Trending Scientists

Leonidas Georgiadis

Leonidas Georgiadis

Aristotle University of Thessaloniki

Wuhua Li

Wuhua Li

Zhejiang University

Neil M. White

Neil M. White

University of Southampton

Neil L. Andrew

Neil L. Andrew

University of Wollongong

L.A. den Hartog

L.A. den Hartog

Wageningen University & Research

Steven A. Whitham

Steven A. Whitham

Iowa State University

Michael Hofreiter

Michael Hofreiter

University of Potsdam

Rüdiger Klein

Rüdiger Klein

Max Planck Society

Stefan Wastegård

Stefan Wastegård

Stockholm University

Paul H. Warren

Paul H. Warren

University of California, Los Angeles

Karl E. Taylor

Karl E. Taylor

Lawrence Livermore National Laboratory

Stephen L. Dewey

Stephen L. Dewey

Feinstein Institute for Medical Research

Aize Kijlstra

Aize Kijlstra

Maastricht University

Charles A. Heywood

Charles A. Heywood

Durham University

David Schottenfeld

David Schottenfeld

University of Michigan–Ann Arbor

Polly A. Newcomb

Polly A. Newcomb

Fred Hutchinson Cancer Research Center

Something went wrong. Please try again later.